Erlotinib hydrochloride (Figure 1) belongs to a group of anti cancer drugs known as inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase which is highly expressed in different forms of cancers. This evidence concerns the gene EGFR and cancer.